Mowery & Schoenfeld Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Mowery & Schoenfeld Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.7K	Hold	46	–	–	0.04%	173
2026 Q1	$35.5K	Sell	46 -2	-4%	-$1.53K	0.05%	145
2025 Q4	$37K	Buy	48 +2	+4%	+$1.36K	0.05%	157
2025 Q3	$25.9K	Sell	46 -6	-12%	-$3.39K	0.04%	158
2025 Q2	$27.3K	Hold	52	–	–	0.04%	157
2025 Q1	$33K	Hold	52	–	–	0.06%	162
2024 Q4	$37K	Buy	+52	New	+$43.6K	0.07%	129

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mowery & Schoenfeld Wealth Management's REGN Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 46 shares worth $28.7K. The position accounts for 0.04% of the portfolio, ranked #173.

Mowery & Schoenfeld Wealth Management first reported a position in REGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $37K in Q4 2025. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Mowery & Schoenfeld Wealth Management held 46 shares of Regeneron Pharmaceuticals worth $28.7K as of Q2 2026.
Mowery & Schoenfeld Wealth Management left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up 0.04% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #173 holding.
Mowery & Schoenfeld Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Mowery & Schoenfeld Wealth Management's Regeneron Pharmaceuticals position peaked at $37K in Q4 2025.
789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.